Hepatic resection provided long-term survival for patients with intermediate and advanced-stage resectable hepatocellular carcinoma

World Journal of Surgical Oncology

Volumn 14, Issue 1, 2016, Pages

  Liu, Wei ^a   Wang, Kun ^a   Bao, Quan ^a   Sun, Yi ^a   Xing, Bao Cai ^a  

^a PEKING UNIVERSITY CANCER HOSPITAL AND INSTITUTE   (China)

Author keywords

Hepatic resection; Hepatocellular; Large; Multinodular; Prognosis

Indexed keywords

ALPHA FETOPROTEIN; EPIRUBICIN; FLUOROURACIL; FOLINATE CALCIUM; OXALIPLATIN;

ADULT; AGED; ARTICLE; CANCER PROGNOSIS; CANCER SURVIVAL; CHEMOEMBOLIZATION; CLINICAL EFFECTIVENESS; DISEASE FREE SURVIVAL; FEMALE; HUMAN; LIVER CELL CARCINOMA; LIVER RESECTION; LONG TERM SURVIVAL; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PATIENT SAFETY; PORTAL VEIN THROMBOSIS; RETROSPECTIVE STUDY; SURVIVAL PREDICTION; SURVIVAL RATE; TREATMENT OUTCOME; TUMOR INVASION; TUMOR VOLUME; CANCER STAGING; CARCINOMA, HEPATOCELLULAR; FOLLOW UP; LIVER NEOPLASMS; MIDDLE AGED; MORTALITY; PATHOLOGY; PROGNOSIS; PROSPECTIVE STUDY; TUMOR RECURRENCE;

CARCINOMA, HEPATOCELLULAR; FEMALE; FOLLOW-UP STUDIES; HEPATECTOMY; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROGNOSIS; PROSPECTIVE STUDIES; RETROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 84959302923     PISSN: None     EISSN: 14777819     Source Type: Journal    
DOI: 10.1186/s12957-016-0811-y     Document Type: Article

References (50)

1. Jemal A, Bray F, Center MM, et al. Global cancer statistics[J]. CA Cancer J Clin. 2011;61(2):69-90.
2. Liu J, Fan D. Hepatitis B in China[J]. Lancet. 2007;369(9573):1582-3.
3. Tang ZY, Ye SL, Liu YK, et al. A decade's studies on metastasis of hepatocellular carcinoma[J]. J Cancer Res Clin Oncol. 2004;130(4):187-96.
4. Makuuchi M, Donadon M, Torzilli G. Hepatic resection for hepatocellular carcinoma in cirrhosis[J]. Ann Ital Chir. 2008;79(2):111-5.
5. Bruix J, Sherman M. Management of hepatocellular carcinoma: an update[J]. Hepatology. 2011;53(3):1020-2.
6. European Association For The Study Of The Liver; European Organisation For Research And Treatment Of Cancer. EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma[J]. J Hepatol. 2012;56(4):908-43.
7. Mazzaferro V, Regalia E, Doci R, et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis[J]. N Engl J Med. 1996;334(11):693-9.
8. Lang H, Sotiropoulos GC, Brokalaki EI, et al. Survival and recurrence rates after resection for hepatocellular carcinoma in noncirrhotic livers[J]. J Am Coll Surg. 2007;205(1):27-36.
9. Yau T, Tang VY, Yao TJ, et al. Development of Hong Kong Liver Cancer staging system with treatment stratification for patients with hepatocellular carcinoma[J]. Gastroenterology. 2014;146(7):1691-700.
10. Shirabe K, Kajiyama K, Abe T, et al. Predictors of microscopic portal vein invasion by hepatocellular carcinoma: measurement of portal perfusion defect area ratio[J]. J Gastroenterol Hepatol. 2009;24(8):1431-6.
11. Makuuchi M, Kokudo N. Clinical practice guidelines for hepatocellular carcinoma: the first evidence based guidelines from Japan[J]. World J Gastroenterol. 2006;12(5):828-9.
12. Aoki T, Imamura H, Hasegawa K, et al. Sequential preoperative arterial and portal venous embolizations in patients with hepatocellular carcinoma[J]. Arch Surg. 2004;139(7):766-74.
13. Cheng CH, Yu MC, Wu TH, et al. Surgical resection of centrally located large hepatocellular carcinoma[J]. Chang Gung Med J. 2012;35(2):178-91.
14. Heng-Jun G, Yao-Jun Z, Min-Shan C, et al. Rationality and effectiveness of transarterial chemoembolization as an initial treatment for BCLC B stage HBV-related hepatocellular carcinoma[J]. Liver Int. 2014;34(4):612-20.
15. Ho MC, Huang GT, Tsang YM, et al. Liver resection improves the survival of patients with multiple hepatocellular carcinomas[J]. Ann Surg Oncol. 2009;16(4):848-55.
16. Hsu CY, Hsia CY, Huang YH, et al. Comparison of surgical resection and transarterial chemoembolization for hepatocellular carcinoma beyond the Milan criteria: a propensity score analysis[J]. Ann Surg Oncol. 2012;19(3):842-9.
17. Jin YJ, Lee JW, Choi YJ, et al. Surgery versus transarterial chemoembolization for solitary large hepatocellular carcinoma of BCLC stage A[J]. J Gastrointest Surg. 2014;18(3):555-61.
18. Jianyong L, Lunan Y, Wentao W, et al. Barcelona clinic liver cancer stage B hepatocellular carcinoma: transarterial chemoembolization or hepatic resection?[J]. Medicine (Baltimore). 2014;93(26):e180.
19. Lee SG, Hwang S, Jung JP, et al. Outcome of patients with huge hepatocellular carcinoma after primary resection and treatment of recurrent lesions[J]. Br J Surg. 2007;94(3):320-6.
20. Lim C, Mise Y, Sakamoto Y, et al. Above 5cm, size does not matter anymore in patients with hepatocellular carcinoma[J]. World J Surg. 2014;38(11):2910-8.
21. Lin CT, Hsu KF, Chen TW, et al. Comparing hepatic resection and transarterial chemoembolization for Barcelona Clinic Liver Cancer (BCLC) stage B hepatocellular carcinoma: change for treatment of choice?[J]. World J Surg. 2010;34(9):2155-61.
22. Ng KK, Vauthey JN, Pawlik TM, et al. Is hepatic resection for large or multinodular hepatocellular carcinoma justified? Results from a multi-institutional database[J]. Ann Surg Oncol. 2005;12(5):364-73.
23. Nojiri K, Tanaka K, Takeda K, et al. The efficacy of liver resection for multinodular hepatocellular carcinoma[J]. Anticancer Res. 2014;34(5):2421-6.
24. Pandey D, Lee KH, Wai CT, et al. Long term outcome and prognostic factors for large hepatocellular carcinoma (10cm or more) after surgical resection[J]. Ann Surg Oncol. 2007;14(10):2817-23.
25. Poon RT, Fan ST, Wong J. Selection criteria for hepatic resection in patients with large hepatocellular carcinoma larger than 10cm in diameter[J]. J Am Coll Surg. 2002;194(5):592-602.
26. Wang JH, Changchien CS, Hu TH, et al. The efficacy of treatment schedules according to Barcelona Clinic Liver Cancer staging for hepatocellular carcinoma-survival analysis of 3892 patients[J]. Eur J Cancer. 2008;44(7):1000-6.
27. Yin L, Li H, Li AJ, et al. Partial hepatectomy vs. transcatheter arterial chemoembolization for resectable multiple hepatocellular carcinoma beyond Milan Criteria: a RCT[J]. J Hepatol. 2014;61(1):82-8.
28. Zhong JH, Ke Y, Gong WF, et al. Hepatic resection associated with good survival for selected patients with intermediate and advanced-stage hepatocellular carcinoma[J]. Ann Surg. 2014;260(2):329-40.
29. Zhong JH, Xiang BD, Gong WF, et al. Comparison of long-term survival of patients with BCLC stage B hepatocellular carcinoma after liver resection or transarterial chemoembolization[J]. PLoS One. 2013;8(7):e68193.
30. Chang WT, Kao WY, Chau GY, et al. Hepatic resection can provide long-term survival of patients with non-early-stage hepatocellular carcinoma: extending the indication for resection?[J]. Surgery. 2012;152(5):809-20.
31. Huang J, Hernandez-Alejandro R, Croome KP, et al. Hepatic resection for huge (>15cm) multinodular HCC with macrovascular invasion[J]. J Surg Res. 2012;178(2):743-50.
32. Ikai I, Yamamoto Y, Yamamoto N, et al. Results of hepatic resection for hepatocellular carcinoma invading major portal and/or hepatic veins[J]. Surg Oncol Clin N Am. 2003;12(1):65-75.
33. Pawlik TM, Poon RT, Abdalla EK, et al. Hepatectomy for hepatocellular carcinoma with major portal or hepatic vein invasion: results of a multicenter study[J]. Surgery. 2005;137(4):403-10.
34. Shi J, Lai EC, Li N, et al. Surgical treatment of hepatocellular carcinoma with portal vein tumor thrombus[J]. Ann Surg Oncol. 2010;17(8):2073-80.
35. Torzilli G, Belghiti J, Kokudo N, et al. A snapshot of the effective indications and results of surgery for hepatocellular carcinoma in tertiary referral centers: is it adherent to the EASL/AASLD recommendations?: an observational study of the HCC East-west study group[J]. Ann Surg. 2013;257(5):929-37.
36. Yang T, Lin C, Zhai J, et al. Surgical resection for advanced hepatocellular carcinoma according to Barcelona Clinic Liver Cancer (BCLC) staging[J]. J Cancer Res Clin Oncol. 2012;138(7):1121-9.
37. Liu L, Miao R, Yang H, et al. Prognostic factors after liver resection for hepatocellular carcinoma: a single-center experience from China[J]. Am J Surg. 2012;203(6):741-50.
38. Chan SL, Mo FK, Johnson PJ, et al. New utility of an old marker: serial alpha-fetoprotein measurement in predicting radiologic response and survival of patients with hepatocellular carcinoma undergoing systemic chemotherapy[J]. J Clin Oncol. 2009;27(3):446-52.
39. Zhong JH, You XM, Lu SD, et al. Historical comparison of overall survival after hepatic resection for patients with large and/or multinodular hepatocellular carcinoma[J]. Medicine (Baltimore). 2015;94(35):e1426.
40. Feo F, Pascale RM. Multifocal hepatocellular carcinoma: intrahepatic metastasis or multicentric carcinogenesis?[J]. Ann Transl Med. 2015;3(1):4.
41. Shah SA, Greig PD, Gallinger S, et al. Factors associated with early recurrence after resection for hepatocellular carcinoma and outcomes[J]. J Am Coll Surg. 2006;202(2):275-83.
42. Llovet JM, Bru C, Bruix J. Prognosis of hepatocellular carcinoma: the BCLC staging classification[J]. Semin Liver Dis. 1999;19(3):329-38.
43. Imamura H, Seyama Y, Kokudo N, et al. One thousand fifty-six hepatectomies without mortality in 8years[J]. Arch Surg. 2003;138(11):1198-206.
44. Ishizawa T, Hasegawa K, Aoki T, et al. Neither multiple tumors nor portal hypertension are surgical contraindications for hepatocellular carcinoma[J]. Gastroenterology. 2008;134(7):1908-16.
45. Cheng HY, Wang X, Chen D, et al. The value and limitation of transcatheter arterial chemoembolization in preventing recurrence of resected hepatocellular carcinoma[J]. World J Gastroenterol. 2005;11(23):3644-6.
46. Ramsey DE, Kernagis LY, Soulen MC, et al. Chemoembolization of hepatocellular carcinoma[J]. J Vasc Interv Radiol. 2002;13(9 Pt 2):S211-21.
47. Kaibori M, Tanigawa N, Matsui Y, et al. Influence of transcatheter arterial chemoembolization on the prognosis after hepatectomy for hepatocellular carcinoma in patients with severe liver dysfunction[J]. Anticancer Res. 2006;26(5B):3685-92.
48. Naugler WE, Alsina AE, Frenette CT, et al. Building the multidisciplinary team for management of patients with hepatocellular carcinoma[J]. Clin Gastroenterol Hepatol. 2015;13(5):827-35.
49. Jiang S, Liu Y, Wang L, et al. A meta-analysis and systematic review: adjuvant interferon therapy for patients with viral hepatitis-related hepatocellular carcinoma[J]. World J Surg Oncol. 2013;11:240.
50. Chan SL, Mo FK, Johnson PJ, et al. Prospective validation of the Chinese University Prognostic Index and comparison with other staging systems for hepatocellular carcinoma in an Asian population[J]. J Gastroenterol Hepatol. 2011;26(2):340-7.